ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,840Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 890

$738K Total Retail Price of All Prescriptions

Rank: 123 out of 890

385 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 385 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

20% of this provider’s 385 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 12,048 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 521 485 1 2
FUROSEMIDE 472 446 2 7
HYDROCODONE-ACETAMINOPHEN 342 241 S3 3 3
LISINOPRIL 317 305 4 4
OMEPRAZOLE 310 275 5 8
DONEPEZIL HCL 298 286 6 30
CITALOPRAM HBR 260 232 7 20
SIMVASTATIN 255 208 8 5
AMLODIPINE BESYLATE 250 208 9 1
NAMENDA 249 249 10 36
METFORMIN HCL 219 166 11 6
WARFARIN SODIUM 207 207 12 24
HYDROCHLOROTHIAZIDE 196 175 13 9
MIRTAZAPINE 194 194 14 82
ESCITALOPRAM OXALATE 191 159 15 51
SERTRALINE HCL 191 173 15 26
ATORVASTATIN CALCIUM 188 174 17 13
METOPROLOL SUCCINATE 188 162 17 17
METOPROLOL TARTRATE 175 166 19 15
GABAPENTIN 164 129 20 12
NEXIUM 151 133 21 14
PRAVASTATIN SODIUM 150 134 22 10
DIGOXIN 138 136 23 65
FAMOTIDINE 136 123 24 90
ZOLPIDEM TARTRATE 134 108 25 19
KLOR-CON M20 133 129 26 72
POLYETHYLENE GLYCOL 3350 130 117 27 67
DIOVAN 126 119 28 33
PANTOPRAZOLE SODIUM 126 83 28 34
MELOXICAM 122 99 30 18
CARVEDILOL 118 116 31 22
QUETIAPINE FUMARATE 110 99 32 73
ATENOLOL 106 106 33 23
POTASSIUM CHLORIDE 105 82 34 11
RANITIDINE HCL 103 82 35 49
LANTUS 103 78 35 50
CLOPIDOGREL 96 90 37 28
FLUTICASONE PROPIONATE 95 87 38 39
TRAMADOL HCL 90 54 39 16
CRESTOR 89 68 40 25
TRAZODONE HCL 88 83 41 40
CYMBALTA 85 65 42 45
LEVOFLOXACIN 84 76 43 107
KLOR-CON M10 84 73 43 165
PREDNISONE 82 82 45 47
RISPERIDONE 79 67 46 78
CLONIDINE HCL 78 47 47 35
BENAZEPRIL HCL 75 75 48 44
VESICARE 75 75 48 188
NITROFURANTOIN 73 58 50 289
CARBIDOPA-LEVODOPA 69 69 51 136
ROPINIROLE HCL 69 66 51 93
CIPROFLOXACIN HCL 67 58 53 58
PLAVIX 67 63 53 42
RAMIPRIL 66 66 55 80
VENLAFAXINE HCL ER 66 60 55 114
SPIRIVA 64 64 57 66
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 60 58 76
ALENDRONATE SODIUM 63 63 58 38
TAMSULOSIN HCL 62 45 60 32
BUSPIRONE HCL 61 46 61 133
MUPIROCIN 60 56 62 121
SEROQUEL 59 50 63 167
EXELON 56 55 64 113
SYNTHROID 55 37 65 53
DOXAZOSIN MESYLATE 54 51 66 70
AZITHROMYCIN 54 41 66 37
LEXAPRO 54 46 66 186
PRAMIPEXOLE DIHYDROCHLORIDE 53 53 69 175
NYSTATIN 53 49 69 173
AMOX TR-POTASSIUM CLAVULANATE 53 47 69 132
NOVOLIN R 52 48 72 153
DILTIAZEM 24HR ER 51 51 73 149
ISOSORBIDE MONONITRATE ER 50 40 74 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.